OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...

Arm China plans to tap Chen Feng (陳鋒), a former executive at Fuzhou, Fujian Province-based chipmaker Rockchip Electronics Co ...

Legacy of Trust and Expertise Ushers in New Era of Precision Medical Device Development and Manufacturing Capabilities ...

Simon Barnett kicked off his morning with a 4.30am alarm, marking his return to More FM today. He joined friend and co-host ...

Explore how AI is transforming the fight against counterfeit goods, improving European soft IP protection and reducing ...

Amy also shares the importance of getting to know the individuals behind the big Pharma logos, which helps patients ... about pushing the diabetes world to design these devices.

January was packed with major highlights— from Mumbai's real estate market seeing a solid 11% growth in property ...

Sol de Janeiro is an American skincare and fragrance brand, founded in 2015 by Heela Yang, a former beauty industry marketing executive in the U.S., who moved to Brazil with her husband in 2008, and ...

Analyst Derek Archila from Wells Fargo maintained a Hold rating on Zentalis Pharmaceuticals (ZNTL – Research Report) and decreased the price ...

A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack. Most of the money from a newly-reached settlement over the fallout of the ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

The yearslong bankruptcy case could be coming to a close. Purdue Pharma’s owners in the Sackler family have agreed to a new $6.5 billion settlement to lawsuits over their role in the U.S. opioid ...